Qualigen Therapeutics(US:QLGN)2026-03-27 20:30Financial Performance - For the fiscal year 2025, AIxCrypto Holdings reported total assets of approximately $31 million, including $19 million in cash and cash equivalents, and total liabilities of approximately $3 million, resulting in stockholders' equity of approximately $28 million[9]. - Net cash used in operating activities for 2025 was approximately $6.95 million, compared to $6.33 million in 2024, reflecting transformation-period general and administrative costs[11]. - The company has established a digital asset treasury with holdings across several major cryptocurrencies valued at approximately $10 million as of year-end 2025[10]. Capital and Investment - The company completed a $41 million private placement in September 2025, strengthening its balance sheet and supporting its transition towards digital asset platform development[6]. - The company plans to expand its Real World Asset (RWA) product offerings, including a $10 million equity tokenization initiative and a partnership with Pinnacle Real Estate Group for real estate loan tokenization[12]. User Engagement and Growth - AIxCrypto launched the AIxC Hub in January 2026, surpassing 5,835,615 registered wallets and 1,392,427 daily active participants as of March 16, 2026[13]. - Management expects revenue growth in 2026 to be driven by EAI and AI Agent-enabled blockchain and RWA activities, with a goal of reaching approximately 100,000 monthly active users across the AIxC ecosystem by year-end[17][16]. Strategic Direction - AIxCrypto's strategic direction includes focusing on the integration of AI, blockchain, and real-world industries, and advancing a clear strategic blueprint for growth[15]. - The company aims to moderate transition-related costs in 2026, supported by a more stable cost structure and disciplined capital allocation[18]. - AIxCrypto has appointed a new executive leadership team, including Co-CEO Jerry Wang and CFO Koti Meka, to drive its strategic initiatives[6].